MariamTek finds profitable solutions for the biggest problems in healthcare and the environment.
MariamTek finds profitable solutions for the biggest problems in healthcare and the environment. We help these solutions reach the market by partnering with a combination of cash flow positive and near-profitable companies.
By developing revolutionary solutions that are set to shake global markets, we can mitigate the risk of biotechnology investment while achieving our vision of sustainable philanthropy. This is all made possible through careful selection, managed development and global deployment.
Natural Fiber Welding and MariamTek bring plant-based leather (Mirum™) to Indian artisans and designers. Goods made from cow leather such as handbags, wallets, belts etc. have significant cultural impediments in India. MariamTek has identified Mirum™ the best, most natural plant-based leather product from Natural Fiber Welding. MariamTek’s goal is to introduce this new material to the consumers in India and license the sale and distribution of Mirum™ to many global markets.
Arterosil and Neo40Pro are two natural supplements that directly affect the health of the blood vessels in the body. Vascular health prevents problems with stroke, heart attacks, kidney failure and erectile dysfunction. MariamTek is deploying these supplements to the global market.
Diabetes Actual’s pulsatile insulin protocol restores insulin sensitivity to cells, helping to ensure that maximal energy is generated. The results are decreased problems from the complications of diabetes including heart disease, stroke, neuropathy, Alzheimer’s, kidney function, erectile dysfunction and wound healing.
What sets Diabetes Actual apart is our combination of additional clinical therapies alongside the PIR protocols. Diabetes Actual are licensing partnerships with regional distributors in the US, the Asia Pacific and GCC countries. Furthermore, there is a launch in the USA Midwest underway, and an imminent plan to launch a new PIR training facility in the GCC and/or India.
Through innovative financial planning, MariamTek has the potential to generate immediate revenue streams for our licensees. In addition, our ILO provides the funding required for the maturation of the next generation of blockbuster technologies.
The technology startups we work with ideally have the potential for large returns, a transformative or disruptive solution, a platform technology with multiple applications, a short development time, a well demarcated regulatory pathway, a strong intellectual property position and demonstrated safety.
Additionally we look at the global market potential including opportunities for regional manufacturing and distribution, recruitment of key opinion leaders among physicians, business people and government ministers. If the solution is related to healthcare, it ideally is a natural product (already in our bodies), be stable & easily transportable, while remaining affordable for all citizens.
We work with a variety of healthcare solutions, with a focus on prevention, treatment and restoration. These cover a range of sectors, including infectious disease, diabetes, atherosclerosis, cancer, tissue damage and aging/dementia. Examples of our technology discoveries include:
1) Pain-free micro-needle vaccination technology provides an easy way to vaccinate the world at 1/10th the cost without cold chain dependency.
2) Our trauma treatment sector features solutions for the global blood bank shortage. Our LifePak is a blood bank in a backpack. This highly portable solution is designed for trauma resuscitation at the scene of injury. There’s no need for blood typing, refrigeration or technicians – helping to save lives.
3) The MG53 natural “molecular bandage” from Axolo repairs injury to cells, which preserves organs and saves lives. This has endless clinical uses such as for stroke, heart attacks, kidney failure, liver damage, lung damage, aging, ALS etc.
MariamTek has a range of environmental partners with solutions to help mitigate the negative effects of petroleum-based plastics and polyester. One of our key partners, Natural Fiber Welding (NFW), has developed a new circular chemical process that adds amazing strength and functionality to plant-based cellulose fibers.
This technology replaces the need for petroleum-based plastics and yarn and will transform the multi-trillion textile, leather-goods, shoe, luggage and furnishing industries. This results in products that are 100% recyclable or compostable. NFW’s technology unlocks the power of plants and supports their rallying cry, “Plants, Not Plastics™.
NFW has already received investment and/or formed partnerships with major fashion producers of polo shirts, shoes and luxury interiors for high end car makers. MariamTek is introducing NFW’s technology to various regions of the world through the supply of their eco-friendly materials to designers, artisans and manufacturers.
Our ILO guarantees that when we make money - you make money.
ILO’s are not based on profits, but gross revenue, or all sales without any costs or taxes subtracted, therefore if you buy our ILO you will make money as we make sales.
These projections are provided by us, MARIAMTEK INC. If you agree they are realistic and achievable, buy our ILO today.
Commencement Date
Next Royalty Expected
Licenses Available
Current Allocation
Total Issued
per license, 10% royalty in year 1
per license, 10% royalty in year 2
per license, 10% royalty in year 3
In addition to paying you a royalty, at the end of the 3rd year MARIAMTEK INC can choose to extend the license for another 3 years, or buy the ILO back for cash should MARIAMTEK INC conduct a major financing.
ILO Value is the estimated value of your ILO in USD ($). This is calculated using our projected revenue numbers. Therefore if our revenue projections are realistic and achievable, this is a good estimation of the buy out price you should expect at different stages.
THIS AGREEMENT is between MARIAMTEK INC (“the Company”), - AND – The Buyer who is the Current License Holder, and who holds this license to promote the companies message to their audience with a view increasing their sales, which will in turn will increase the royalty to all license holders. The Buyer is determined by the Live Ledger held by ILOCX which holds details of licenses issued bought and sold (“the Buyer”).
January 30, 2021
Details of the Licensed Product are described on the Company’s page hosted on the site at www.ILOCX.com
None
Minimum Requirements for Qualification are a confirmed share of the Company’s information and Promotional Message on social media. This can be done on the ILOCX platform. Alternative ways to qualify are at the discretion of the company selling the license.
$10
Under the License Agreement the buyer is entitled to royalty payments once qualified
Each License receives a royalty equal to 10% of the Gross Revenues from the recorded and officially filed revenue, divided by 50,000, the total amount of ILO Units in the Initial License Offering. All royalties will be paid to the Buyer’s wallet on the ILOCX platform within 5 days of payment settlement from the company. These days will be announced prior to release.
This License is for an Initial Term of 3 years at which time the License can be extended by the issuing Company for a further 3 years, (a “Rollover”) and new terms may be set by the company at this time in line with ILOCX exchange rules and guidelines. Alternatively, the Company may offer to buy the License back from the Buyer (“a ‘Buyback”). The Company will give notice of Rollover terms or Buyback Price 90 days before the end of the Initial Term, as outlined in the Buyer Terms and Conditions.
All licenses must be valid and deemed qualified to benefit from the Royalty and the Rollover or Buyback.
This Agreement should be read in conjunction with the License Terms and Conditions, the Company Terms and Conditions, the Buyer Terms and Conditions and the ILOCX Terms of Use which form part of this entire Agreement, as well all ILOCX rules, policies, rulings and procedural requirements (collectively the “ILOCX Terms and Conditions”).
All parties have read and agreed to comply with the ILOCX Terms and Conditions, this Agreement, and any documents included by reference above. These may be amended from time to time and the parties will be notified by email of such amendments. Breach of any of the terms of this agreement may result in termination of this Agreement under the termination procedures outlined in the License Terms and Conditions.
This Agreement shall be governed by the laws of Delaware, USA and the parties exclusively submit to the jurisdiction of the Courts of Delaware, USA. In the event of any dispute, refer to the terms and conditions for the procedure.
Agreed on behalf of the Company:
The Company confirms its consent to this License Agreement by presenting the ILO for sale on the ILOCX platform.
Agreed on behalf of the Buyer:
The Buyer consents to this agreement by completing their order on ILOCX.
ILOCX is pleased to announce the listing of Diabetes Actual, a MariamTek brand that seeks to restore metabolic wellness.
This will be achieved through the use of proven therapies for reversing the ravages of diabetes by restoring insulin sensitivity.
ILOCX is pleased to announce the listing of MariamTek. MariamTek finds profitable solutions to life’s problems in healthcare and the environment and brings them to the world market.
Diabetes Actual seeks to restore metabolic wellness through the use of proven therapies for reversing the ravages of diabetes by restoring insulin sensitivity.
RememberMe seeks to unite families through their innovative App, which stores valuable memories to share with future generations.
ELI Ident is an automated AI-based biometric system, offering blazingly fast, secure and cost-effective verification services to both businesses and individuals.
LuxMods has emerged as a new leader in modular housing, with the modular home market is expected to grow to over 114 billion by 2028, and LuxMods projecting over $170 million in revenue in the next 3 years alone.
